| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702882 | American Journal of Ophthalmology | 2017 | 25 Pages |
Abstract
The change of the DRIL extent following the first 3 monthly injections identifies eyes with a high likelihood of subsequent BCVA improvement or decline. Therefore, the extent of DRIL before and after treatment is an additional SD-OCT parameter that may serve as a biomarker for patients with RVO-ME.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Michael Mimouni, Or Segev, Dalia Dori, Noa Geffen, Victor Flores, Ori Segal,